A Study of SGN-CD228A in Advanced Solid Tumors
Conditions: Cutaneous Melanoma; Pleural Mesothelioma; Breast Cancer; Non-small Cell Lung Cancer; Colorectal Cancer; Pancreatic Ductal Adenocarcinoma Intervention: Drug: SGN-CD228A Sponsor: Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Asbestosis | Cancer | Cancer & Oncology | Genetics | Melanoma | Mesothelioma | Research | Skin Cancer | Study